lecture 17: logic modeling of cell signaling networks€¦ · biochemistry 49: 3216 [2010] j...
TRANSCRIPT
LOGIC MODELING OF
CELL SIGNALING NETWORKS
J Saez-Rodriguez – Molecular Systems Biology 5: 331 [2009]
MK Morris – Biochemistry 49: 3216 [2010]
J Saez-Rodriguez – Cancer Research 71: 5400 [2011]
MK Morris – PLoS Computational Biology 7: e1001099 [2011]
1
Central Topic:
extracellular ligand ‘cues’
‘signals’
behavior ‘response’
(phenotype)
Regulation of Mammalian Cell Behavior by Receptor-Mediated Signaling
[‘execution’– transcription / translation,
metabolism / synthesis, cytoskeleton / motors]
Source: Hanahan, Douglas, and Robert A. Weinberg. "The Hallmarks of Cancer." Cell 100, no. 1 (2000): 57-70.
2
Courtesy of Elsevier, Inc., http://www.sciencedirect.com. Used with permission.
Objective: Learn how cell signaling network cell / tissue
operation – in multi-pathway manner -- differs phenotypic behaviorbetween normal and disease state
or among various individuals
environmental context altered behavior of
cellular ��machines��
and ��circuits��
expression protein levels
DNA dynamicmRNA sequence protein operationsgene
variations / mutations
3
Example: Myriad -- and highly diverse -- genetic alterations (amplifications, deletions, mutations) across pancreatic tumors… (as well as in breast, colon, brain)
© American Association for the Advancement of Science. All rights reserved. This content is excludedfrom our Creative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Jones, Siân, Xiaosong Zhang, et al. "Core Signaling Pathways in Human Pancreatic CancersRevealed by Global Genomic Analyses." Science 321, no. 5897 (2008): 1801-6.
[[JJoonneess eett aall..,, SScciieennccee ((22000088)) ]] !! 4
…but diverse mutations lead to dysregulation of a limited set of key pathways at protein level
© American Association for the Advancement of Science. All rights reserved. This content is excludedfrom our Creative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Jones, Siân, Xiaosong Zhang, et al. "Core Signaling Pathways in Human Pancreatic CancersRevealed by Global Genomic Analyses." Science 321, no. 5897 (2008): 1801-6.
[[JJoonneess eett aall..,, SScciieennccee ((22000088)) ]] !! 5
…but diverse mutations lead to dysregulation of a limited set of key pathways at protein level
© American Association for the Advancement of Science. All rights reserved. This content is excludedfrom our Creative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Jones, Siân, Xiaosong Zhang, et al. "Core Signaling Pathways in Human Pancreatic CancersRevealed by Global Genomic Analyses." Science 321, no. 5897 (2008): 1801-6.
[[JJoonneess eett aall..,, SScciieennccee ((22000088)) ]] !! 6
Cell Signaling ��Circuitry��
Need to advance
from Metaphor
to Model
© Scientific American Library. All rights reserved. This content is excluded from our CreativeCommons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Varmus, H., and R. A. Weinberg. "The Genetic Elements Governing Cancer: Tumor SuppressorGenes." Genes and The Biology of Cancer (1993): 101-9.
Varmus & Weinberg, Genes & the Biology of Cancer [1993] 7
Spectrum of Computational Modeling Methods
SPECIFIED ABSTRACTED
differential equations
Boolean/fuzzy logic, decision trees
Bayesian networks mutualmechanisms information
logic regression, clusteringinfluences
topology
relationships
��prior knowledge�� needed
8
Database Pathways Relevant No. Genes Format GeneGO 700+ 55 804 Table
PANTHER 165 14 1,025 SBML CellMap (NetPATH) 20 12 625 BioPAX / SIF
Reactome 1081 4 173 BioPAX / SIF NCI-PID 104 28 459 BioPAX / SIF KEGG 1000+ 8 564 -
SUMMARY 120 2,054
Pathway / Interactome Databases hold substantial prior knowledge
Pathway Databases (Nodes)
Interactome Databases (Edges) Database Type No. Edges Graph type i2D v1.71 Protein-Protein (Exp) 11,327 Undirected STRING Integrated Text mining 35,033 Mixture GeneGo Curated 11,994 Directed, Signed Cell Map Curated 12,933 Mixture NCI-PID Curated 14,58 Mixture
Reactome Curated 6,930 Mixture SUMMARY 68,067 Mixture
© Respective copyright holders. All rights reserved. This content is excluded from our CreativeCommons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.
9
Pathway / Interactome Databases hold substantial ��prior knowledge�� for integrative analysis of multi-pathway network effects; but, there is need to move forward from illustration to prediction
EREG HBEGF
ERBB4
© source unknown. All rights reserved. This content is excluded from our Creative
Shortcomings:
• Typically diverse withNode Source respect to specificity and≥ 2
GeneGo context – i.e.,KEGG NCI-PID cell type, genomic content,NetPATH and/or environmentalPANTHER Reactome conditions
• Do not readily permit ��input-output�� calculation of network operating behavior, and thus difficult to relate to
phenotype and/or interventions
Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.
© Respective copyright holders. All rights reserved. This content is excluded from our CreativeCommons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.
10
© source unknown. All rights reserved. This content is excluded from our CreativeCommons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.
Central Goal:
Establish methodology for converting from qualitative
cell pathway topology ��maps�� to quantitatively
computable network models
Approach:
Employ logic-based modeling framework, to train qualitative ��prior knowledge�� maps to
quantitative empirical data for system context and
multi-pathway comparisons of interest
11
More Detailed Insights from Stronger Modeling Analysis -- integrating empirical data with prior knowledge
using network logic approach
Network Logic ModelGeneric Pathway Map (e.g., Ingenuity) Boolean operators:
nodes (=compounds), AND / OR / NOTsigned directed edges (activation +, inhibition -)
AND A B C
E F
G
S
AND
OR
NOT
NOT
A B C
E
��!!
F
G��!!
+ ++
+ +
+
12
Primary Hepatocytes HepG2 Huh7 Hep3B FocusFocus
© source unknown. All rights reserved. This content is excluded from our Creative
Example Study: Comparative Hepatocytic Cell SignalingNetwork Operation in Inflammation Context
hepatocellular lineshepatocellular lines
Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/. 13
[7 ligands + control]
X [7 inhibitors + control]
X 17 signals = ~ 1000
measurements for each
cell-type and time-point and
replicate
Multi-Pathway Phosphoproteomic Data – primary human hepatocytes, HepG2 hepatocellular line
LATE TRANSIENT
NO RESPONSE SUSTAINED
Time-points: 0, 30 min, 3 hrs
© source unknown. All rights reserved. This content is excluded from our CreativeCommons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.
-- also cell death, proliferation index, and production of ~50 cytokines for each condition
14
Example Database Pathway Map
from literature curation, for network responses
to our cytokine and growth factor treatments
from Ingenuity supplemented by some literature
knowledge for key receptors
-- 82 nodes, 116 edges
© source unknown. All rights reserved. This content is excluded from our CreativeCommons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.
15
Choose Submap
Process DataNormalize between 0,1Filter noise, saturation
STOP?
Compare experiment - simulation
Import Data
Define Pathway Mapfrom literature/Database
Perform Experiments
Analyzeresulting model
CellNetOptimizer
DataRail
YESNO
EGF TNF
Ikb
0
870
Evaluate model Sum deviations + Size
1
0
0
1
Dev
iatio
n
Import Map
AND OR
EGF TNF
EGF TNF
Ikb
Ikb
TNFR EGFR
PI3K
AKT
IKKab
Ikb
TNF EGF
TNF EGF
IKKab
Ikb
TNFR EGFR
PI3K
AKTIKKab
Ikb
TNF EGF
OR
TNFR EGFR
PI3K
AKT
IKKab
TNF EGF
AND
TNF EGF
IKKab
Ikb
OR
Ikb
Process MapCompress & Remove non-observables
X
Training Prior Pathway Map Knowledge on Context-Specific Empirical Signaling Data
Create Boolean Scaffold
XX
© source unknown. All rights reserved. This content is excluded from our Creative
Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.
Automated Development of Logic Network Models from Fit of Generic Pathway Map to Experimental Data
as an Optimization Problem
Objective θ = θ f + α ⋅ θS
Size of modelFit to data
θ f = (Bikl M − Bikl
E )2 K =1
M
∑ l=1
S
∑ θS = ν k Pk k=1
n
∑ Relative
importance Fit vs. Size
Function
∈ [0,1)∈ {0,1}∈ {0,1}
© source unknown. All rights reserved. This content is excluded from our CreativeCommons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.
! minimize Objective Function (θ) across model variants (P), ! trading off model-data error and model size;
! αα ascertained by Pareto optimum for false-positive vs false- negative trade-offs
! obtain family of best-fit models (within 1% of Objective Function optimum)
17
Automated Development of Logic Network Models from Fit of Generic Pathway Map to Experimental Data
as an Optimization Problem
Genetic Algorithm 1. Initialize a population of model variants (from Ingenuity
scaffold or from random scaffolds) 2. Evaluate objective function (model-vs-data error plus model-
size penalty) for each individual in the population 3. Generate next generation of population using Elite Survival,
Fitness Selection, Mutation, and Crossover 4. Assess whether stop criterion is fulfilled, or iterate back to
step 2 5. Model pruning to reduce model size without detriment to
model-vs-data error 6. 100 runs for each value of model-size penalty αα
18
Illustration for HepG2 cell line
– improvement in data fit from best-fit original
scaffold model to best-fit trained model
Training data fit to ~9% error, substantially improved from original scaffold model fit of
>45% error
19© source unknown. All rights reserved. This content is excluded from our CreativeCommons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.
Illustration for HepG2 cell line
– consensus model from fit of empirical data to initial prior knowledge
scaffold -- additional arcs needed
to improve model fit, support in literature though not in prior knowledge scaffold
-- arcs present in other cell line models but not in
HepG2
Courtesy of EMBO and Nature Publishing Group. License: CC-BY-NC-SA.Source: Saez‐Rodriguez, Julio, Leonidas G. Alexopoulos, et al. "Discrete Logic Modelling as a Means toLink Protein Signalling Networks with Functional Analysis of Mammalian Signal Transduction."Molecular Systems Biology 5, no. 1 (2009).
20
Model size is fairly insensitive to size penalty
Objective function = Fit of data (MSE) + α Size
200 0.2
160
0 10 10 10 10 Size penalty !
selected model-size penalty, for maximal predictive capability
© source unknown. All rights reserved. This content is excluded from our CreativeCommons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.
Substantial number of scaffold arcs not supported
by hepatocyte data MS
E !
f
Obje
ctive function !
Siz
e !
S 0.15 120
80
40
0.1
0.05
00 -3-7 -5 -1
21
0% identifiability
* *
Models can only be partially identified -- thus model families are best outcome
Frequency of Arc Distribution for Error Tolerance-Related (i.e., beyond exptl uncertainty) Model Families
arc frequency
© source unknown. All rights reserved. This content is excluded from our CreativeCommons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.
22
Trade-off between False Negatives and False Positives
• Receiver Operating Characteristic (ROC) curve [ratio of true positives (1-false negatives) vs. false positives] for different values of the size penalty α
• Optimal choice of size penalty (α=10-5) corresponds to most predictive model
• Extended model (i.e., with added arcs) decreases false negatives but increases false positives
© source unknown. All rights reserved. This content is excluded from our CreativeCommons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.
23
24
Model Validation -- successful a priori
predictions of new test data
! Used trained model to a priori predict effects of ligand combinations,
additional inhibitors, and inhibitor combinations
! New test data predicted to within ~11% error,
comparable to ~9% for original training data
! Can identify loci needing more detailed inquiry
0 0.5 1
Agree Disagree
© source unknown. All rights reserved. This content is excluded from our CreativeCommons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.
Extension to comparison among hepatocellular lines -- phosphoproteomic data
© American Association for Cancer Research. All rights reserved. This content is excluded from ourCreative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Saez-Rodriguez, Julio, Leonidas G. Alexopoulos, et al. "Comparing Signaling NetworksBetween Normal and Transformed Hepatocytes Using Discrete Logical Models."Cancer Research 71, no. 16 (2011): 5400-11. 25
Demonstration of benefit of cell type-specific models
Demonstration of capability to identify particular points
inviting further study
© American Association for Cancer Research. All rights reserved. This content is excluded from ourCreative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Saez-Rodriguez, Julio, Leonidas G. Alexopoulos, et al. "Comparing Signaling NetworksBetween Normal and Transformed Hepatocytes Using Discrete Logical Models."Cancer Research 71, no. 16 (2011): 5400-11.
26
Best-Fit Boolean Logic Model Families
for Primaries versus Lines
• Arc width corresponds to proportion of best-fit models bearing it • Black arcs – all models in both primaries and HCC lines • Blue arcs – most or all primary models • Red arcs – most or all HCC line models • Gray arcs deleted from original scaffold • Dashed arc added to account for especially recalcitrant data
© American Association for Cancer Research. All rights reserved. This content is excluded from ourCreative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Saez-Rodriguez, Julio, Leonidas G. Alexopoulos, et al. "Comparing Signaling NetworksBetween Normal and Transformed Hepatocytes Using Discrete Logical Models."Cancer Research 71, no. 16 (2011): 5400-11. 27
Best-Fit Boolean Logic Model Families
for Primaries versus Lines
• ~90% of original scaffold interactions were found in at least one best-fit model across families for all cell types • but only <10% were found both in most primary cell models and cell line models • multiple pathways are identifiable as dysregulated from normal to tumor lines
© American Association for Cancer Research. All rights reserved. This content is excluded from ourCreative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Saez-Rodriguez, Julio, Leonidas G. Alexopoulos, et al. "Comparing Signaling NetworksBetween Normal and Transformed Hepatocytes Using Discrete Logical Models."Cancer Research 71, no. 16 (2011): 5400-11. 28
Model permits novel insights concerning
drug actions
Dashed arc added to fit data generated in presence of IKK inhibitor TPCA1 – two potential explanations: • IKK activity suppresses STAT3 activity downstream of JAK2; or • TPCA1 has off-target effect on JAK2
© American Association for Cancer Research. All rights reserved. This content is excluded from ourCreative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Saez-Rodriguez, Julio, Leonidas G. Alexopoulos, et al. "Comparing Signaling NetworksBetween Normal and Transformed Hepatocytes Using Discrete Logical Models."Cancer Research 71, no. 16 (2011): 5400-11. 29
Experimental validation of model prediction that putative IKK inhibitor TPCA1 hits JAK2 as an off-target substrate (whereas BMS-345541 does not)
© American Association for Cancer Research. All rights reserved. This content is excluded from ourCreative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Saez-Rodriguez, Julio, Leonidas G. Alexopoulos, et al. "Comparing Signaling NetworksBetween Normal and Transformed Hepatocytes Using Discrete Logical Models."Cancer Research 71, no. 16 (2011): 5400-11.
…perhaps providing an explanation for why TPCA1 has been found to be more efficacious for airway inflammation treatment than other IKK inhibitors
30
Best-Fit Boolean Logic Model Families
-- comparison among HCC Lines
• cell-type specificity of network operation is thus explicitly characterized – not only contrasting primaries to tumor lines but also disparities between different tumor lines
© American Association for Cancer Research. All rights reserved. This content is excluded from ourCreative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Saez-Rodriguez, Julio, Leonidas G. Alexopoulos, et al. "Comparing Signaling NetworksBetween Normal and Transformed Hepatocytes Using Discrete Logical Models."Cancer Research 71, no. 16 (2011): 5400-11.
31
Cell types can be quantitatively clustered with respect to common edges
-- reasonable similarity to transcriptomic result
© American Association for Cancer Research. All rights reserved. This content is excluded from ourCreative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Saez-Rodriguez, Julio, Leonidas G. Alexopoulos, et al. "Comparing Signaling NetworksBetween Normal and Transformed Hepatocytes Using Discrete Logical Models."Cancer Research 71, no. 16 (2011): 5400-11. 32
Detailed Primary-vs-Lines Comparison
• 8 edges are strongly disparate between primary
hepatocytes and the HCC lines
© American Association for Cancer Research. All rights reserved. This content is excluded from ourCreative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Saez-Rodriguez, Julio, Leonidas G. Alexopoulos, et al. "Comparing Signaling NetworksBetween Normal and Transformed Hepatocytes Using Discrete Logical Models."Cancer Research 71, no. 16 (2011): 5400-11. 33
Detailed Primary-vs-Lines Comparison – insights gained
• Whereas EGFR leads to ERK activation in all cell
types, HSP27 is significantly activated
downstream of ERK only in primaries
• In the lines, HSP27 was activated more mildly and via p38 instead of via ERK
(Literature: HCC tumor
progression is associated with
decreased HSP27 activation --
despite HSP27 over-expression)
© American Association for Cancer Research. All rights reserved. This content is excluded from ourCreative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Saez-Rodriguez, Julio, Leonidas G. Alexopoulos, et al. "Comparing Signaling NetworksBetween Normal and Transformed Hepatocytes Using Discrete Logical Models."Cancer Research 71, no. 16 (2011): 5400-11. 34
Detailed Primary-vs-Lines Comparison – insights gained
© American Association for Cancer Research. All rights reserved. This content is excluded from our
• In primaries Ikb phosphorylation
requires TNFa-NIK and activation of PI3K-JNK
(via TGFa or Ins), whereas in lines only TNFa-NIK is required
(Literature: HCC tumor
progression is associated with looser control
over NFkB-mediated
survival signals)
Creative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Saez-Rodriguez, Julio, Leonidas G. Alexopoulos, et al. "Comparing Signaling NetworksBetween Normal and Transformed Hepatocytes Using Discrete Logical Models."Cancer Research 71, no. 16 (2011): 5400-11. 35
Detailed Primary-vs-Lines Comparison – insights gained
© American Association for Cancer Research. All rights reserved. This content is excluded from our
• GSK3 phosphorylation by
Akt (leading to nuclear activation of pro-mitotic factors)
is induced by Insulin in lines but not in
primaries
(Literature: IRS1 is over-expressed in
HCC, potentially shifting Insulin-
induced signaling from IRS2-mediated metabolism to proliferation)
Creative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Saez-Rodriguez, Julio, Leonidas G. Alexopoulos, et al. "Comparing Signaling NetworksBetween Normal and Transformed Hepatocytes Using Discrete Logical Models."Cancer Research 71, no. 16 (2011): 5400-11. 36
These same three pathways have been implicated in
combination kinase therapy for HCC
IKK Akt p38
© American Association for Cancer Research. All rights reserved. This content is excluded fromour Creative Commons license. For more information, see http://ocw.mit.edu/help/faq-fair-use/.Source: Pritchard, Justin R., Benjamin D. Cosgrove, et al. "Three-kinase Inhibitor CombinationRecreates Multipathway Effects of a Geldanamycin Analogue on Hepatocellular Carcinoma CellDeath." Molecular Cancer Therapeutics 8, no. 8 (2009): 2183-92.
37
��Constrained Fuzzy Logic�� Framework
allows Analog Model rather than Digital
Courtesy of Morris et al. License: CC-BY.Source: Morris, Melody K., Julio Saez-Rodriguez, et al. "Training Signaling Pathway Maps to Biochemical Datawith Constrained Fuzzy Logic: Quantitative Analysis of Liver Cell Responses to Inflammatory Stimuli."PLoS Computational Biology 7, no. 3 (2011): e1001099. 38
HepG2 Constrained Fuzzy Logic Network Model (again consensus family)
Extracellular cues
Protein signals
Courtesy of Morris et al. License: CC-BY.Source: Morris, Melody K., Julio Saez-Rodriguez, et al. "Training Signaling Pathway Maps to Biochemical Datawith Constrained Fuzzy Logic: Quantitative Analysis of Liver Cell Responses to Inflammatory Stimuli."PLoS Computational Biology 7, no. 3 (2011): e1001099.
IGF1
Ras PI3K
IL1a
TRAF6
IL6
STAT3
LPS TGF!TNF!
MKK4
MAP3K7
JNK1/2
MEK1/2MAP3K1 Akt
IKK
p53 I"B
p38
0.18 ± 0.08
0.38 ±0.43 ±
p70s6
p90RSKMSK1/2
IRS1sHsp27
mTOR
Gsk3 CREBHistH3c-Jun
0.6 ± 0.15
0.41 ± 0.04 0.06 ± 0.01 0.2 ± 0.08
0.11 ± 0.05
0.59 ±0.17
0.450.15*
0.13 ± 0.08
0.38 ± 0.09 0.32 ± 0.13
0.2 ± 0.08
0.5 ± 0
0.68 ± 0.18
0.3 ±0.07
0.49 ± 0.15
0.7
5 ±
0.1
8
0.49 ± 0.16
0.1
9 ±
0.0
5
0.57 ± 0.19
0.37 ±0.13
0.17
0.66 ±0.14
0.6
± 0.1
3
0.8 ± 0.16
0.20.34 ± 0.18
0.5
± 0.1
7
0.28 ± 0.11
0.38 ± 0.16
0.62 ±
0.41 ± 0.17 0.68 ±
0.11
*
Intensity of arc = likelihood of connection
Numerical descriptor = upstream-downstream effect strength
* = new arcs not identified by Boolean model 39
40
0.2
0.6 ± 0.15
0.18 ± 0.08
0.59 ± 0.17
0.2 ± 0.08
0.3 ± 0.07
0.7
5 ±
0.1
8
0.1
9 ±
0.0
5
0.57 ± 0.19
0.37 ± 0.13
0.38 ± 0.17
0.66 ± 0.14 0.45
0.6
± 0
.13
0.5
± 0.1
7
0.62 ± 0.2
0.68 ± 0.15
0.43 ± 0.11
1.2
1
0.8
0.6
0.4
Example Results for Quantitative Cell Circuit Logic -- downstream ��child�� node versus upstream ��parent�� nodes
Red points: experimental values Gray points: averaged-model predictions Gold points: individual model predictions
TNF! IL1a LPS TGF! IGF1 0.38 ± 0.09
0.32 ± 0.13
0.13 ± 0.08 0.41 ± 0.04 0.06 ± 0.01
IL6
0.5 ± 0
0.2 ± 0.08 PI3KRasTRAF6
0.41 ± 0.17
0.11 ± 0.05
MAP3K7 MAP3K1 Akt MEK1/2
MKK4 IKK 0
-0.2 JNK1/2 p38 1
0.49 ± 0.150.9 0.8 1 0.8 ± 0.16
0.7 0.9 MSK1/2 p90RSK
0.34 ± 0.18
mTOR
0.68 ± 0.18 0.49 ± 0.16
0.6 0.8 0.70.5 0.6 0.38 ± 0.16
0.4 0.50.3 0.4 0.28 ± 0.11MEK1/2 0.2 0.3 c-Jun Hsp27 p53 I"B Gsk3 HistH3 CREB IRS1s p70s6 STAT30.20.1
0 0 p380.1
Courtesy of Morris et al. License: CC-BY.Source: Morris, Melody K., Julio Saez-Rodriguez, et al. "Training SignalingPathway Maps to Biochemical Data with Constrained Fuzzy Logic:Quantitative Analysis of Liver Cell Responses toInflammatory Stimuli."PLoS Computational Biology 7, no. 3 (2011): e1001099.
CREB
New test data fell within one standard deviation
of predictions across all conditions
© source unknown. All rights reserved. This content is excludedfrom our Creative Comm ons license. For mor e information, seehttp://ocw.mit.edu/help/faq-fair-use/.
Model family precision generally presages accuracy
Courtesy of Morris et al. License: CC-BY.Source: Morris, Melody K., Julio Saez-Rodriguez, et al. "Training Signaling Pathway Maps to Biochemical Datawith Constrained Fuzzy Logic: Quantitative Analysis of Liver Cell Responses to Inflammatory Stimuli."PLoS Computational Biology 7, no. 3 (2011): e1001099. 41
MIT OpenCourseWarehttp://ocw.mit.edu
7.91J / 20.490J / 20.390J / 7.36J / 6.802J / 6.874J / HST.506J Foundations of Computational and Systems BiologySpring 2014
For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.